[go: up one dir, main page]

MX2024000930A - Composiciones que comprenden un constituyente, derivado o extracto de cannabis. - Google Patents

Composiciones que comprenden un constituyente, derivado o extracto de cannabis.

Info

Publication number
MX2024000930A
MX2024000930A MX2024000930A MX2024000930A MX2024000930A MX 2024000930 A MX2024000930 A MX 2024000930A MX 2024000930 A MX2024000930 A MX 2024000930A MX 2024000930 A MX2024000930 A MX 2024000930A MX 2024000930 A MX2024000930 A MX 2024000930A
Authority
MX
Mexico
Prior art keywords
derivative
extract
cannabis
constituent
composition
Prior art date
Application number
MX2024000930A
Other languages
English (en)
Inventor
Karina Mcquillan
Thomas Poole
Michael Daniel
Steven Alderman
Kai Tang
Keyi Xu
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of MX2024000930A publication Critical patent/MX2024000930A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones que comprenden un constituyente, derivado o extracto de cannabis en una solución o en una forma solubilizada. La invención también se refiere a productos que incluyen dichas composiciones y métodos para fabricar las mismas.
MX2024000930A 2021-07-22 2022-07-21 Composiciones que comprenden un constituyente, derivado o extracto de cannabis. MX2024000930A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163224622P 2021-07-22 2021-07-22
PCT/GB2022/051905 WO2023002199A1 (en) 2021-07-22 2022-07-21 Composition comprising a constituent, derivative or extract of cannabis

Publications (1)

Publication Number Publication Date
MX2024000930A true MX2024000930A (es) 2024-02-07

Family

ID=82898766

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024000930A MX2024000930A (es) 2021-07-22 2022-07-21 Composiciones que comprenden un constituyente, derivado o extracto de cannabis.

Country Status (8)

Country Link
US (1) US20240251841A1 (es)
EP (1) EP4373300A1 (es)
JP (1) JP2024530406A (es)
AU (1) AU2022315590A1 (es)
CA (1) CA3224624A1 (es)
IL (1) IL309702A (es)
MX (1) MX2024000930A (es)
WO (1) WO2023002199A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE547629C2 (en) 2024-01-18 2025-10-28 Vont Ab Natural chewing gum with nicotine and manufacturing method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2033909A (en) 1934-12-19 1936-03-17 Niacet Chemicals Corp Manufacture of calcium levulinate
US3901248A (en) 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US5387416A (en) 1993-07-23 1995-02-07 R. J. Reynolds Tobacco Company Tobacco composition
EP1539069A4 (en) * 2002-05-31 2007-11-14 Univ Mississippi TRANSMUCOSAL DELIVERY OF CANNABINOIDS
CA2511185C (en) 2002-12-20 2012-09-18 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
EP1681949A2 (en) 2003-11-03 2006-07-26 U.S. Smokeless Tobacco Company Flavored smokeless tabacco and methods of making
WO2005046363A2 (en) 2003-11-07 2005-05-26 U.S. Smokeless Tobacco Company Tobacco compositions
AU2007312233B2 (en) * 2006-10-20 2012-09-20 Abbvie B.V. Micellar nanoparticles of chemical substances
WO2018058235A1 (en) * 2016-09-27 2018-04-05 CannTab Therapeutics Limited Sustained release cannabinoid formulations
CA3108112A1 (en) * 2018-07-18 2020-01-23 Glatt Gmbh Multiparticulate formulations of cannabinoids

Also Published As

Publication number Publication date
WO2023002199A1 (en) 2023-01-26
EP4373300A1 (en) 2024-05-29
IL309702A (en) 2024-02-01
AU2022315590A1 (en) 2024-01-18
US20240251841A1 (en) 2024-08-01
CA3224624A1 (en) 2023-01-26
JP2024530406A (ja) 2024-08-21

Similar Documents

Publication Publication Date Title
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CL2017002335A1 (es) Composiciones de cosmetica topica para combatir radicales libres
MX2018011348A (es) Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades.
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
MX380850B (es) Composiciones solubles en agua que comprenden cannabinoides purificadas
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
MX2021001716A (es) Composiciones novedosas, su uso y metodos para su formacion.
AR100562A1 (es) Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
AR101236A1 (es) Composiciones para el cuidado oral
MX2019015124A (es) Composicion que comprende manosa oligosacarido y proceso para realizarla y uso de esta.
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
CL2020003373A1 (es) Composición y método de ahorro de opiáceos
CO2021017697A2 (es) Mejoramientos en o relacionados con compuestos orgánicos
CR11078A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
CL2019002516A1 (es) Composiciones cosméticas para el cuidado de la piel.
CL2019002514A1 (es) Composiciones cosméticas para el cuidado de la piel.
MX2024010977A (es) Composiciones que comprenden aticaprant
MX2024000930A (es) Composiciones que comprenden un constituyente, derivado o extracto de cannabis.
CO2019000604A2 (es) Composición vaginal que comprende una combinación de estrógeno y vitamina d
CL2018001161A1 (es) Composición dermocosmética, proceso de producción de la composición tópica, método para el fortalecimiento de uñas frágiles y uso de la composición
CL2015003798A1 (es) Composición natural antioxidante y antibacteriana, elaborada a partir de extractos fenolicos de aristotelia chilensis y procesos de obtención.
MX2021004444A (es) Composicion tratada termicamente que comprende proteinas vegetales y metodos de produccion y uso de esta.
CL2022003714A1 (es) Métodos y composiciones para uso en productos de madera encolados.
MX2022007720A (es) Extractos enriquecidos con compuestos polifenolicos y metodos relacionados.
BR112017018618A2 (pt) odorizante de osmanthus